Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitors
Loughlin, Wendy A., Pierens, Gregory K., Petersson, Maria J., Henderson, Luke C. and Healy, Peter C. 2008, Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitors, Bioorganic & medicinal chemistry, vol. 16, no. 11, pp. 6172-6178, doi: 10.1016/j.bmc.2008.04.047.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitors
The lipophilicity, permeability, solubility, polar surface area and ‘rule-of-five’ properties were assessed, using QikProp v2.5 (Schrödinger, Inc.) and ALOGPS 2.1 calculations, for 25 Hyphodermin derivatives. These compounds obeyed the ‘rule-of-five’, and the calculated physicochemical values were generally within desired limits. All compounds were tested against Glycogen Phosphorylase a (GPa). Four phenyl and benzyl substituted 2-oxo-hexahydro and tetrahydrobenzo[cd]indole carboxylic acids were identified as novel inhibitors of GPa with estimated IC50 values in the range 0.8–1.3 mM. Molecular modelling of these novel inhibitors was used to obtain the main structural features of this class of molecule for future structure–activity relationship studies.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.